
Johnson & Johnson plans to break up into two companies, splitting off the $15-billion-a-year division that sells Band-Aid bandages, Tylenol medicines and Johnson’s Baby Powder in a shift indicating just how much healthcare has changed since the company helped pioneer the industry.
The world’s largest health-products company by sales will separate its high-margin but less predictable prescription-drug and medical-device businesses from its storied but slower-growing consumer group, creating two publicly traded companies, reported The Wall Street Journal.
“The best path forward to ensure sustainable growth over the long term and better meet patient and consumer demands is to have our consumer business operate as a separate healthcare company,” Mr. Gorsky said in an interview.
What form the separation will take, what the new consumer-oriented company will be called and who will lead it are yet to be worked out, Mr. Gorsky said, though he said J&J planned to structure the transaction to be tax-free.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Top Australian Law Firms Target ACCC Talent Ahead of Major Merger Reforms
May 11, 2025 by
CPI
What the Google Antitrust Trial Has Revealed So Far
May 11, 2025 by
CPI
Hamlin Remains Confident in 23XI, Front Row Antitrust Case Against NASCAR
May 11, 2025 by
CPI
Google Faces €2.97 Billion Lawsuit in Italy Over Alleged Market Abuse
May 11, 2025 by
CPI
UFC Finalizes $375 Million Settlement in Fighter Antitrust Case
May 11, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Mergers in Digital Markets
Apr 21, 2025 by
CPI
Catching a Killer? Six “Genetic Markers” to Assess Nascent Competitor Acquisitions
Apr 21, 2025 by
John Taladay & Christine Ryu-Naya
Digital Decoded: Is There More Scope for Digital Mergers In 2025?
Apr 21, 2025 by
Colin Raftery, Michele Davis, Sarah Jensen & Martin Dickson
AI In the Mix – An Ever-Evolving Approach to Jurisdiction Over Digital Mergers in Europe
Apr 21, 2025 by
Ingrid Vandenborre & Ketevan Zukakishvili
Antitrust Enforcement Errors Due to a Failure to Understand Organizational Capabilities and Dynamic Competition
Apr 21, 2025 by
Magdalena Kuyterink & David J. Teece